Transketolase promotes MAFLD by limiting inosine-induced mitochondrial activity
2024-05-07
发表期刊CELL METABOLISM (IF:27.7[JCR-2023],31.2[5-Year])
ISSN1550-4131
EISSN1932-7420
卷号36期号:5
发表状态已发表
DOI10.1016/j.cmet.2024.03.003
摘要

Metabolic dysfunction -associated fatty liver disease (MAFLD) has a global prevalence of about 25% and no approved therapy. Using metabolomic and proteomic analyses, we identified high expression of hepatic transketolase (TKT), a metabolic enzyme of the pentose phosphate pathway, in human and mouse MAFLD. Hyperinsulinemia promoted TKT expression through the insulin receptor-CCAAT/enhancer-binding protein alpha axis. Utilizing liver -specific TKT overexpression and knockout mouse models, we demonstrated that TKT was sufficient and required for MAFLD progression. Further metabolic flux analysis revealed that Tkt deletion increased hepatic inosine levels to activate the protein kinase A-cAMP response element binding protein cascade, promote phosphatidylcholine synthesis, and improve mitochondrial function. Moreover, insulin induced hepatic TKT to limit inosine-dependent mitochondrial activity. Importantly, N-acetylgalactosamine (GalNAc)-siRNA conjugates targeting hepatic TKT showed promising therapeutic effects on mouse MAFLD. Our study uncovers how hyperinsulinemia regulates TKT-orchestrated inosine metabolism and mitochondrial function and provides a novel therapeutic strategy for MAFLD prevention and treatment.

URL查看原文
收录类别SCI
语种英语
资助项目National Key Research and Development Program of China[
WOS研究方向Cell Biology ; Endocrinology & Metabolism
WOS类目Cell Biology ; Endocrinology & Metabolism
WOS记录号WOS:001239829500001
出版者CELL PRESS
引用统计
正在获取...
文献类型期刊论文
条目标识符https://kms.shanghaitech.edu.cn/handle/2MSLDSTB/387262
专题生命科学与技术学院
生命科学与技术学院_PI研究组_李扬扬组
通讯作者Liu, Junling; Tong, Xuemei
作者单位
1.Shanghai Jiao Tong Univ, Dept Biochem & Mol Cell Biol, Shanghai Key Lab Tumor Microenvironm & Inflammat, Key Lab Cell Differentiat & Apoptosis,Chinese Min, Shanghai 200025, Peoples R China
2.Shanghai Tech Univ, Sch Life Sci & Technol, Unit Immune & Metab Regulat, Shanghai 201210, Peoples R China
3.Shanghai Jiao Tong Univ, RenJi Hosp, Sch Med, Dept Liver Surg, Shanghai 200127, Peoples R China
4.Fudan Univ, Dept Biochem & Mol Biol, Key Lab Metab & Mol Med, Minist Educ,Sch Basic Med Sci,Shanghai Med Coll, Shanghai 200032, Peoples R China
5.Gladstone UCSF Inst Genom Immunol, San Francisco, CA USA
6.Shanghai Jiao Tong Univ, Renji Hosp, Sch Med, Dept Radiol, Shanghai 200127, Peoples R China
7.Shanghai Jiao Tong Univ, Pediat Translat Med Inst, Shanghai Childrens Med Ctr, Key Lab Pediat Hematol & Oncol,Sch Med,Minist Hlt, Shanghai 200127, Peoples R China
8.Shanghai Jiao Tong Univ, Shanghai Gen Hosp, Natl Clin Res Ctr Eye Dis, Shanghai Key Lab Ocular Fundus Dis,Dept Ophthalmo, Shanghai 200032, Peoples R China
9.Shanghai Jiao Tong Univ, Shanghai Peoples Hosp 9, Sch Med, Dept Ophthalmol, Shanghai 200011, Peoples R China
10.Shanghai Jiao Tong Univ, Ctr Brain Sci, Shanghai Childrens Med Ctr, Sch Med, Shanghai 200062, Peoples R China
11.Shanghai Jiao Tong Univ, Sch Med, Dept Anat & Physiol, Shanghai 200025, Peoples R China
12.Shanghai Jiao Tong Univ, Shanghai Inst Immunol, Sch Med, Dept Immunol & Microbiol, Shanghai 200025, Peoples R China
13.Shanghai Synvida Biotechnol Co Ltd, Shanghai, Peoples R China
推荐引用方式
GB/T 7714
Tong, Lingfeng,Chen, Zhangbing,Li, Yangyang,et al. Transketolase promotes MAFLD by limiting inosine-induced mitochondrial activity[J]. CELL METABOLISM,2024,36(5).
APA Tong, Lingfeng.,Chen, Zhangbing.,Li, Yangyang.,Wang, Xinxia.,Yang, Changjie.,...&Tong, Xuemei.(2024).Transketolase promotes MAFLD by limiting inosine-induced mitochondrial activity.CELL METABOLISM,36(5).
MLA Tong, Lingfeng,et al."Transketolase promotes MAFLD by limiting inosine-induced mitochondrial activity".CELL METABOLISM 36.5(2024).
条目包含的文件
文件名称/大小 文献类型 版本类型 开放类型 使用许可
个性服务
查看访问统计
谷歌学术
谷歌学术中相似的文章
[Tong, Lingfeng]的文章
[Chen, Zhangbing]的文章
[Li, Yangyang]的文章
百度学术
百度学术中相似的文章
[Tong, Lingfeng]的文章
[Chen, Zhangbing]的文章
[Li, Yangyang]的文章
必应学术
必应学术中相似的文章
[Tong, Lingfeng]的文章
[Chen, Zhangbing]的文章
[Li, Yangyang]的文章
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。